Stoke Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.418; its P/E ratio is -5.80; Stoke Therapeutics is scheduled to report earnings on August 5, 2024, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Income Statement	-
Total Revenue	$ 4.22M	$ 2.80M	$ 3.31M	$ -2.48M	$ 5.15M
Gross Profit	$ 4.22M	$ 2.80M	$ 3.31M	$ -2.48M	$ 5.15M
EBIT	$ -26.37M	$ -26.96M	$ -24.54M	$ -30.65M	$ -24.65M
EBITDA	$ -25.84M	$ -26.39M	-	$ -30.19M	$ -24.02M
Net Income Common Stockholders	$ -26.37M	$ -26.96M	$ -24.54M	$ -30.65M	$ -22.55M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 178.58M	$ 201.39M	$ 214.72M	$ 231.45M	$ 253.67M
Total Assets	$ 205.18M	$ 228.34M	$ 239.89M	$ 256.92M	$ 281.80M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -178.58M	$ -201.39M	$ -214.72M	$ -231.45M	$ -253.67M
Total Liabilities	$ 64.84M	$ 68.78M	$ 66.89M	$ 66.72M	$ 67.97M
Stockholders Equity	$ 140.34M	$ 159.56M	$ 173.00M	$ 190.19M	$ 213.82M
Cash Flow	-
Free Cash Flow	$ -24.58M	$ -20.88M	-	$ -22.64M	$ -21.52M
Operating Cash Flow	$ -24.57M	$ -20.65M	$ -17.26M	$ -21.80M	$ -21.36M
Investing Cash Flow	$ 9.99M	$ 14.77M	$ 14.62M	$ 23.47M	$ 53.09M
Financing Cash Flow	$ 1.72M	$ 7.34M	$ 562.00K	$ 48.00K	$ 45.05M

Currency in USD

Stoke Therapeutics Earnings and Revenue History

Income Statement >

Stoke Therapeutics Debt to Assets

Balance Sheet >

Stoke Therapeutics Cash Flow

Cash Flow >

Stoke Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing